ElendiLabs — Regulatory consultancy platform connecting medical device and pharmaceutical manufacturers with verified experts worldwide
All regulatory hubs
Regulatory hub

Overview of the Health Sciences Authority (HSA) and Medical Device Regulation in Singapore

An overview of Singapore's HSA, its role in classifying medical devices (Class A-D), and the regulatory requirements for registration and licensing.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

Health Sciences Authority (HSA) - Medical Device Regulation in Singapore

The Health Sciences Authority (HSA) is the national regulatory body in Singapore responsible for ensuring the safety, quality, and efficacy of medical devices. Under the Health Products Act, HSA oversees the entire lifecycle of medical devices, from pre-market registration to post-market surveillance.

1. Regulatory Role and Responsibilities

HSA regulates the import, manufacture, export, and supply of medical devices. Its primary objectives are to:

  • Safeguard Public Health: Ensuring that only safe and effective devices reach the market.
  • Define Medical Devices: Identifying products with physical or mechanical effects used for diagnosis, treatment, or monitoring.
  • Market Oversight: Managing dealer licenses for manufacturers, importers, and wholesalers.

2. Risk-Based Classification

Singapore follows a four-tier risk classification system for medical devices (excluding in-vitro diagnostics, which have their own rules):

  • Class A (Low Risk): Examples include tongue depressors, bandages, and surgical masks.
  • Class B (Low-Moderate Risk): Examples include hypodermic needles and suction pumps.
  • Class C (Moderate-High Risk): Examples include lung ventilators and orthopedic implants.
  • Class D (High Risk): Examples include heart valves and pacemakers.

3. Product Registration

All medical devices (except Class A) must be registered with HSA before they can be supplied in Singapore.

  • Evaluation Routes: Registration can follow different routes (Full, Abridged, Expedited, or Immediate) depending on whether the device has prior approvals from reference agencies like the US FDA or EU CE marking.
  • Class A Exemption: Most Class A devices are exempt from pre-market registration but must still meet safety requirements and be listed if they are sterile or have a measuring function.

4. Dealer Licensing

Any company involved in the supply chain must obtain a dealer's license:

  • Manufacturer's License: Required for companies manufacturing devices in Singapore.
  • Importer's License: Required to bring devices into Singapore from overseas.
  • Wholesaler's License: Required for the local supply of devices to other companies or healthcare facilities.

5. Post-Market Surveillance

HSA monitors devices after they are on the market through:

  • Adverse Event Reporting: Mandatory reporting of device-related incidents.
  • Field Safety Corrective Actions (FSCA): Managing recalls and safety updates.
  • Post-Market Audits: Ensuring ongoing compliance with Good Distribution Practice (GDPMDS) and ISO 13485.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Registration

March 6, 2026

Singapore HSA Drug Master File Submission for Therapeutic Products

HSA requires Drug Master Files (DMFs) to be submitted only in conjunction with a therapeutic product application; they contain confidential manufacturing details divided into open and closed parts, with notification via an online form required before submission of PDF dossiers.

Read article

Registration

March 4, 2026

How to Register Therapeutic Products in Singapore: HSA Eligibility, Application Types, Evaluation Routes and Pre-Submission Requirements

HSA Singapore mandates that only ACRA-registered local companies may apply for therapeutic product registration (chemical or biological entities) via PRISM. Applicants must select NDA or GDA application types, choose among Full, Abridged, Verification or Verification-CECA evaluation routes, prepare ICH CTD or ACTD dossiers, complete patent declarations and ensure GMP compliance for overseas manufacturers.

Read article

Post Market Surveillance

February 4, 2026

When to Report Field Safety Corrective Actions in Singapore

Manufacturers must report Field Safety Corrective Actions (FSCA) to HSA when a device presents an unacceptable risk or when corrective measures are needed to reduce risk, including recalls, design modifications, and labelling changes.

Read article

Medical Advertisements

February 3, 2026

Advertising and Promotion Rules for Medical Devices in Singapore

Advertisements and promotions of medical devices in Singapore must be accurate, substantiated, and comply with HSA guidelines to avoid misleading claims and ensure public safety.

Read article

Other

February 3, 2026

Pre-Market Consultation Schemes for Medical Devices in Singapore

HSA offers pre-submission consultation services to help applicants clarify regulatory requirements and prepare high-quality dossiers for medical device registration, licensing, or other applications.

Read article

Post Market Surveillance

February 3, 2026

Adverse Event Reporting for Medical Devices in Singapore

Healthcare professionals, manufacturers, importers, and suppliers in Singapore are required to report serious adverse events involving medical devices to HSA within specified timelines to support post-market safety monitoring.

Read article

Registration

February 3, 2026

Singapore HSA Abridged Registration Pathway for Class B Medical Devices

The Health Sciences Authority (HSA) of Singapore offers an abridged registration route for Class B medical devices that have obtained prior approval from specified reference agencies, allowing reduced documentation requirements and faster review compared to full registration while maintaining safety and performance standards.

Read article

Other

February 2, 2026

HSA Innovation Office for Medical Devices in Singapore

HSA's Innovation Office partners with industry to provide early regulatory guidance, pre-market consultations, and initiatives like reliance programmes, SaMD change management, and cybersecurity labelling to accelerate access to innovative medical devices.

Read article

Other

February 2, 2026

Personal Import of Medical Devices in Singapore

Individuals in Singapore may personally import certain medical devices for their own use under specific quantity limits and conditions, but many higher-risk devices require HSA authorisation or are prohibited without proper approval.

Read article

Other

February 2, 2026

Custom-Made Medical Devices Regulatory Pathway in Singapore

Custom-made medical devices in Singapore are exempt from full registration but require notification to HSA, with specific labelling, documentation, and record-keeping obligations to ensure patient safety.

Read article

Other

February 2, 2026

Singapore HSA Special Access Routes for Export of Unregistered Medical Devices

The Health Sciences Authority (HSA) of Singapore provides special access routes allowing export of unregistered medical devices under specific conditions, such as for demonstration, exhibition, testing, clinical trial supply, or personal use, with streamlined notification or approval processes to facilitate legitimate international trade while maintaining regulatory oversight.

Read article

Other

February 2, 2026

Singapore HSA Grouping Guidelines for IVD Test Kits

The Health Sciences Authority (HSA) of Singapore provides specific grouping rules for in vitro diagnostic (IVD) test kits, allowing multiple kits with the same manufacturer, risk class, analyte, and detection principle to be registered together in one application, while ensuring separate listings for different proprietary names on the Singapore Medical Device Register.

Read article

Other

February 2, 2026

Singapore HSA Single Device Registration Pathway

The Health Sciences Authority (HSA) of Singapore applies a single device registration pathway for medical devices that do not qualify for grouping, family, system, or other special grouping categories, requiring a full individual application with complete documentation tailored to the device's specific design, intended use, and risk class.

Read article

Other

February 1, 2026

Singapore-Malaysia Medical Device Regulatory Reliance Programme

HSA and Malaysia's MDA have launched a 6-month pilot programme (Sep 2025 – Feb 2026) allowing faster registration of Class B, C and D medical devices by relying on each other's assessments, reducing review times significantly.

Read article

Clinical Trials

February 1, 2026

Conducting Clinical Trials for Medical Devices in Singapore

Clinical trials of medical devices in Singapore require prior approval from HSA unless exempted, with requirements including ethics committee approval, qualified investigators, and compliance with good clinical practice standards.

Read article

Post Market Surveillance

February 1, 2026

Types of Field Safety Corrective Actions for Medical Devices in Singapore

Field Safety Corrective Actions in Singapore include recalls, design modifications, software updates, labelling changes, and user advice to mitigate unacceptable risks associated with marketed medical devices.

Read article

Post Market Surveillance

February 1, 2026

Reporting Field Safety Corrective Actions to HSA in Singapore

Manufacturers must submit Field Safety Corrective Action reports to HSA within 2 working days of initiation, including the Field Safety Notice and details of affected devices and corrective measures.

Read article

Other

February 1, 2026

Quality Management System Requirements for Medical Device Dealers in Singapore

Medical device dealers in Singapore must implement and maintain an appropriate Quality Management System such as GDPMDS or ISO 13485 depending on licence type to ensure consistent quality, safety, and performance throughout distribution activities.

Read article

Other

February 1, 2026

PHMC Request for Unregistered Medical Devices in Singapore

The PHMC Request SAR allows licensed healthcare facilities in Singapore to import and supply unregistered medical devices for patient use in emergencies or when alternatives fail, requiring HSA approval and clinical justification.

Read article

Other

February 1, 2026

Consignment Import of Registered Medical Devices in Singapore via SAR

The Consignment Registered Special Access Route allows unauthorised dealers to import registered medical devices in Singapore with HSA approval, requiring specific licences and documentation.

Read article

Other

February 1, 2026

Singapore HSA Priority Review Scheme for Medical Devices

The Health Sciences Authority (HSA) of Singapore operates a Priority Review Scheme to accelerate evaluation of medical devices that address unmet clinical needs, represent breakthrough innovations, or provide significant public health benefits, offering reduced review timelines while upholding rigorous safety and efficacy standards.

Read article

Registration

February 1, 2026

Singapore HSA Full Registration Requirements for Class B Medical Devices

The Health Sciences Authority (HSA) of Singapore requires Class B medical devices to undergo full registration with a complete technical dossier submitted by the Singapore Authorized Representative, including conformity to Essential Principles, risk management, performance data, and labeling, followed by HSA evaluation and issuance of registration approval.

Read article

Other

February 1, 2026

Singapore HSA IVD Cluster Grouping for Registration

The Health Sciences Authority (HSA) of Singapore permits grouping of in vitro diagnostic (IVD) reagents and test kits into clusters when they share the same manufacturer, risk class, intended purpose, and core detection technology, allowing multiple related products to be registered in a single application while requiring separate SMDR listings for distinct proprietary names.

Read article

Other

February 1, 2026

Singapore HSA Device Family Grouping for Registration

The Health Sciences Authority (HSA) of Singapore allows grouping of medical devices into a 'family' for registration when they share the same manufacturer, risk class, intended use, and fundamental design, enabling a single application for multiple models with limited variants while requiring justification of differences to optimize the regulatory pathway.

Read article

Registration

February 1, 2026

Singapore HSA Grouping Guidelines for FISH Probes IVD

The Health Sciences Authority (HSA) of Singapore provides guidelines for grouping Fluorescence In Situ Hybridization (FISH) probes IVD reagents and accessories, allowing a single registration application for products meeting specific criteria, such as same manufacturer, risk class, and category, to streamline the process while ensuring separate listings for different proprietary names.

Read article

Registration

January 31, 2026

Singapore HSA Grouping Rules for IVD Analysers

The Health Sciences Authority (HSA) of Singapore permits grouping of in vitro diagnostic (IVD) analysers for registration when they share the same manufacturer, risk class, intended use category, and core technical platform, allowing a single application for multiple models while requiring separate listings for distinct proprietary names on the Singapore Medical Device Register.

Read article

Other

January 30, 2026

Singapore HSA System Grouping for Medical Device Registration

The Health Sciences Authority (HSA) of Singapore allows grouping of medical devices as a 'system' for registration when they consist of multiple components intended to function together as a single entity, share the same manufacturer and risk class, and meet specific criteria, enabling a single application while requiring separate listings for distinct proprietary names on the Singapore Medical Device Register.

Read article

Registration

January 30, 2026

Singapore HSA Grouping for Hearing Aids Registration

The Health Sciences Authority (HSA) of Singapore allows grouping of hearing aids for registration under specific conditions, permitting a single application for multiple models with identical core components and performance characteristics, while imposing limits on the number of variants and requiring justification for differences to streamline the regulatory process.

Read article

Registration

January 30, 2026

Overview of Medical Device Registration in Singapore

The Health Sciences Authority (HSA) of Singapore provides a risk-based registration framework for medical devices, requiring manufacturers to obtain approval via the ABCD risk classification system before market access, with requirements varying from notification for low-risk Class A devices to full evaluation for high-risk Class D devices.

Read article

Other

January 29, 2026

Amending Medical Device Dealer's Licence in Singapore

Dealers must notify HSA of changes to their medical device licence details in Singapore, such as QMS certifications and site addresses, to maintain validity, submitting amendments via the SHARE system.

Read article

Other

January 29, 2026

Import of Unregistered Pre-Owned Medical Devices Returned from Maintenance or Repair in Singapore

This Special Access Route allows licensed dealers in Singapore to import unregistered pre-owned medical devices that were previously exported for maintenance or repair, requiring prior HSA approval and specific documentation to ensure compliance.

Read article

Registration

January 29, 2026

Singapore HSA Abridged Registration Pathway for Class D Medical Devices

The Health Sciences Authority (HSA) of Singapore provides an abridged registration route for high-risk Class D medical devices that have obtained prior approval from designated reference agencies, enabling reduced documentation requirements and a more focused review process compared to full registration while ensuring equivalent high standards of safety and performance.

Read article

Other

January 27, 2026

Qualified Practitioner Request for Unregistered Medical Devices in Singapore

The Qualified Practitioner Request SAR allows import and supply of unregistered medical devices in Singapore for patient use upon a doctor's or dentist's request, with HSA approval in emergencies or when alternatives fail.

Read article

Registration

January 27, 2026

Singapore HSA Expedited Registration Pathway for Class D Medical Devices

The Health Sciences Authority (HSA) of Singapore offers an expedited registration route for high-risk Class D medical devices with prior approval from designated reference agencies, providing accelerated review with targeted evaluation and reduced documentation compared to full registration while maintaining stringent safety and performance standards.

Read article

Registration

January 27, 2026

Singapore HSA Full Registration Requirements for Class D Medical Devices

The Health Sciences Authority (HSA) of Singapore requires comprehensive full registration for high-risk Class D medical devices, involving submission of an extensive technical dossier by the Singapore Authorized Representative, including detailed risk management, clinical evidence, performance data, and conformity assessment, followed by rigorous HSA evaluation before approval and listing on the Singapore Medical Device Register.

Read article

Registration

January 27, 2026

Singapore HSA Grouping Framework for IVF Media

The Health Sciences Authority (HSA) of Singapore allows grouping of in vitro fertilisation (IVF) media products for registration when they share the same manufacturer, intended use, risk class, and formulation principles, enabling a single application for multiple variants while requiring separate listings for distinct proprietary names on the Singapore Medical Device Register.

Read article

Other

January 26, 2026

Certificates of Free Sale and Conformity for Medical Devices in Singapore

The Health Sciences Authority issues Certificates of Free Sale and Certificates of Conformity to support Singapore-registered medical devices for export, demonstrating compliance with local regulatory standards.

Read article

Other

January 26, 2026

Renewing Medical Device Dealer's Licence in Singapore

Medical device dealers in Singapore must renew their licences before expiry through the SHARE system, submitting updated QMS documents to maintain authorisation for manufacturing, import, or wholesale activities.

Read article

Other

January 26, 2026

Applying for Medical Device Dealer's Licence in Singapore

Companies in Singapore must apply for a dealer's licence to manufacture, import, or wholesale medical devices, submitting via the SHARE system with required QMS certifications.

Read article

Registration

January 25, 2026

Singapore HSA Abridged Registration Pathway for Class C Medical Devices

The Health Sciences Authority (HSA) of Singapore offers an abridged registration route for Class C medical devices with prior approval from designated reference agencies, allowing reduced documentation and accelerated review compared to full registration while ensuring equivalent safety and performance standards.

Read article

Registration

January 25, 2026

Singapore HSA Risk Classification Rules for Medical Devices

The Health Sciences Authority (HSA) of Singapore applies 16 classification rules to determine the risk class (A to D) of medical devices based on intended use, duration of contact, invasiveness, and active nature, ensuring appropriate regulatory controls for safety and performance.

Read article

Registration

January 24, 2026

Singapore HSA Full Registration Requirements for Class C Medical Devices

The Health Sciences Authority (HSA) of Singapore mandates full registration for Class C medical devices (moderate to high risk), requiring a comprehensive technical dossier submitted by the Singapore Authorized Representative, including detailed risk management, performance testing, clinical evidence, and conformity to Essential Principles, followed by thorough HSA evaluation before approval and SMDR listing.

Read article

Registration

January 24, 2026

Singapore HSA Immediate Registration Route for Class B Medical Devices

The Health Sciences Authority (HSA) of Singapore provides an immediate registration pathway for certain Class B medical devices that have prior approval from designated reference agencies, enabling rapid market entry with minimal HSA review through a streamlined notification process upon submission of required documents.

Read article

Registration

January 23, 2026

Singapore HSA Expedited Registration Pathway for Class C Medical Devices

The Health Sciences Authority (HSA) of Singapore provides an expedited registration route for Class C medical devices with prior approval from designated reference agencies, offering a faster review process with targeted evaluation and reduced documentation compared to full registration while upholding safety and performance requirements.

Read article

Other

January 19, 2026

Singapore HSA Device Grouping for Registration

The Health Sciences Authority (HSA) of Singapore allows grouping of medical devices under a single registration when they share the same manufacturer, risk class, intended purpose and fundamental design principles, enabling efficient submission of related models or variants while requiring justification of differences and separate listings for distinct proprietary names on the Singapore Medical Device Register.

Read article

Registration

January 17, 2026

Singapore HSA Abridged Registration for Class D Medicinal Product Medical Devices

The Health Sciences Authority (HSA) of Singapore offers an abridged registration pathway for high-risk Class D drug-device combination products that have obtained prior approval from designated reference agencies, allowing reduced documentation and targeted review while maintaining rigorous safety, quality, and efficacy standards for the combined product.

Read article

Other

January 15, 2026

Singapore HSA Special Access Routes for Non-Clinical Purpose Medical Devices

The Health Sciences Authority (HSA) of Singapore permits the import, export, or supply of unregistered medical devices for non-clinical purposes such as demonstration, exhibition, performance testing, research, or training through a streamlined special access notification process, enabling controlled use without full registration while ensuring no patient exposure.

Read article

Registration

January 11, 2026

Singapore HSA Immediate Registration Route for Class C Medical Devices

The Health Sciences Authority (HSA) of Singapore offers an immediate registration pathway for specific Class C medical devices with prior approval from designated reference agencies, enabling very rapid market entry through a streamlined notification and minimal review process while maintaining necessary safety and performance standards.

Read article

Registration

January 2, 2026

Singapore HSA Full Registration for Class D Medicinal Product Medical Devices

The Health Sciences Authority (HSA) of Singapore requires full registration for Class D medical devices that incorporate medicinal substances as an integral component (drug-device combinations), involving submission of a comprehensive technical dossier demonstrating safety, quality, and efficacy of both the device and medicinal aspects, with rigorous HSA evaluation before approval and SMDR listing.

Read article

Singapore SaMD Regulation overview showing definitions of Software as a Medical Device, IMDRF risk classifications Class A–D, and key regulatory focus areas including cybersecurity requirements, versioning & traceability, change management, and AI-powered device compliance.
Registration

December 16, 2025

Singapore's SaMD Regulation: Cybersecurity, AI, and Compliance

The HSA regulates all Software as a Medical Device (SaMD), including AI and mobile apps, under a lifecycle approach. Registration requires adhering to the IMDRF risk classification and demonstrating a strong **cybersecurity strategy** (Secure-by-Design, threat modeling). SaMD labeling must include precise **versioning**, and changes, particularly to algorithms or AI features, are subject to rigorous **Change Notification** review.

Read article

Post Market Surveillance

November 16, 2025

Post-Market Surveillance: Mandatory Adverse Event Reporting

Singapore's HSA mandates post-market surveillance for all medical devices under the Health Products Act. The local **Registrant/Distributor** is primarily responsible for reporting Adverse Events (AEs) occurring in Singapore, which must be reported within **48 hours (public health threat)** to **30 days (potential serious injury upon recurrence)**, depending on the severity. Manufacturers are responsible for providing all necessary information, with the clock starting immediately upon notification of the event.

Read article

Registration

November 16, 2025

Medical Device License Maintenance: Annual Fees and Change Notifications

Maintaining a medical device registration in Singapore requires payment of an **Annual Retention Fee** and mandatory reporting of all changes via **Registration Modification (Change Notifications)** to the HSA. Changes are categorized as Administrative, Review, or Technical, with processing times ranging from **30 to 90 days** depending on the device class and the nature of the change. Major changes, such as a change in intended use, require a **new product registration**.

Read article

Registration

October 16, 2025

Medical Device Labeling: HSA Compliance and AMDD Harmonization

Singapore's HSA mandates medical device and IVD labeling be in **English** and align with the **ASEAN Medical Devices Directive (AMDD)**, detailed in **GN-23**. The label must contain information for safe identification and use, including product owner details, batch/lot number, and sterilization status. IVDs have additional requirements covering intended purpose, performance characteristics, and specimen type.

Read article

Registration

October 16, 2025

Medical Device Classification in Singapore: A Risk-Based GHTF Approach

Singapore’s Health Sciences Authority (HSA) classifies medical devices (MD) and IVDs into four risk classes (**Class A, B, C, D**) following **GHTF guidance**. Risk is determined by factors like intended use, invasiveness, and duration of contact. Higher-risk devices require more stringent registration. Special rules apply to **Software as a Medical Device (SaMD)** and devices for telehealth or aesthetic purposes.

Read article

Registration

September 16, 2025

Singapore's GDPMDS: The Mandatory QMS for Medical Device Distribution

The **Good Distribution Practice for Medical Devices (GDPMDS)**, formalized under SS 620:2016, is a mandatory Quality Management System (QMS) standard in Singapore. It is enforced by the **HSA** and required for all companies involved in the **importation and wholesale** of medical devices and IVDs. GDPMDS certification is the foundational step for obtaining a Medical Device Dealer's License.

Read article

Registration

August 16, 2025

Medical Device Grouping for Registration in Singapore: HSA's Cost-Saving Pathways

Singapore's HSA permits medical device and IVD manufacturers to consolidate multiple products into a single registration application through various grouping mechanisms, such as **Family**, **System**, and **Group**. This approach reduces costs and processing time, provided the devices share criteria like intended purpose, risk class, and design. Specific rules exist for IVD analyzers, test kits, and dental devices.

Read article

Registration

July 16, 2025

IVD Device Registration in Singapore: HSA's Risk-Based Reliance Pathways

The HSA regulates IVD devices in Singapore based on GHTF risk classification (A-D). Registration leverages approvals from **Reference Countries** to determine the pathway (Immediate, Expedited, Abridged, or Full), thereby significantly reducing review times, which can range from **0 working days** (Immediate) to **310 working days** (Full for Class D). All applications must be submitted by a local **Registrant**.

Read article

Registration

March 16, 2025

Medical Device Registration in Singapore: HSA's Multi-Route Reliance System

Singapore's HSA regulates medical device registration using a risk-based classification (Class A-D) and four reliance pathways: Immediate, Expedited, Abridged, and Full. Registration requires a local **Registrant** and is facilitated by approvals in **Reference Countries** to streamline the process and reduce review timelines from 310 days (Full) to immediate.

Read article